Table 1. The demographic, clinical, and laboratory characteristics of all female study patients.
Variables | |
---|---|
Patients—n | 23 |
Female—n (%) | 23 (100) |
Age—years (SD) | 50 (9) |
High blood pressure—n (%) | 9 (39) |
Diabetes mellitus—n (%) | 2 (8) |
Dyslipidemia—n (%) | 2 (8) |
Beta blocker—n (%) | 3 (13) |
SSRI—n (%) | 3 (13) |
ACE inhibitor—n (%) | 4 (17) |
ARB—n (%) | 5 (21) |
Calcium channel blocker—n (%) | 2 (8) |
Diuretic—n (%) | 3 (13) |
Metformin—n (%) | 2 (8) |
LVEF—% mean (SD) | 65 (2.9) |
SSRI: selective serotonin reuptake inhibitor, ACE: angiotensin-converting enzyme, ARB: angiotensin receptor blocker, LVEF: left ventricular ejection fraction, and SD: standard deviation.